Nextseq 500 comprehensive plan service maintenance for systems serial number NS500296 and NS500287

Ended Purchase Order Awarded Last action

Contract number
HHSF223201610534P
Awardee
Awarding agency
Obligated
$265,801

Award facts

Contract value 100% obligated
$265,801.32 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Berwyn Heights, MD 20740, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00009 -$17
Exercise an Option P00008 $31,025
Exercise an Option P00007 · Exercise option year 4 for comprehensive plan service maintenance for systems serial number NS500287 $0
Other Administrative Action P00006 · Funding for option year 3 for comprehensive plan service maintenance for systems serial number NS500296 and NS500287 $59,663
Exercise an Option P00005 · Exercise of option year 3 for comprehensive plan service maintenance for systems serial number NS500296 and NS500287 $0
Other Administrative Action 4 $57,368
Exercise an Option 3 $0
Exercise an Option 2 $55,162
Exercise an Option 1 $0
Original award $62,600

About this award

This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for NEXTSEQ 500 comprehensive plan service maintenance for two NextSeq 500 sequencing systems at the FDA's location in Berwyn Heights, Maryland. The contract has a ceiling value of $265,801.32 and a period of performance through September 30, 2021. This contract does not have a set-aside designation. Illumina has been awarded numerous prime federal contracts and grants across multiple agencies, including the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Department of Agriculture (USDA), Department of Veterans Affairs (VA), and FDA, to provide advanced genomic sequencing technologies and associated services. Illumina also holds Indefinite Delivery Vehicles with the VA valued at $231,165 and $1,297,062 for the procurement of Illumina reagents, sequencing platforms, maintenance services, and bioinformatics products.

Quick answers

Who was awarded contract HHSF223201610534P?

HHSF223201610534P was awarded to Illumina, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 6, 2016.

How much is contract HHSF223201610534P worth?

The government has obligated $265,801 on HHSF223201610534P.

Was contract HHSF223201610534P competed?

The extent of competition for HHSF223201610534P was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award